This article appears in the January 2026 print edition with the headline “The Most Powerful Man in Science.” ...

In the aftermath of the COVID-19 pandemic, Africa articulated the ambitious the New Public Health Order (NPHO) to strengthen ...

The mutated strain, known as subclade K, is causing a surge in cases in the United Kingdom, Canada, and Japan. Here's what to ...

Agency admits research hasn't "ruled out" vaccine-autism link, subject of four-year-old lawsuit. "The CDC has simply been ...

A mutated strain of the flu is surging worldwide, sparking concerns about a severe flu season in the U.S. Here's what to ...

AI brings its own validation challenges. Unlike static assays, machine learning algorithms evolve as they ingest new data, ...

“The claim ‘vaccines do not cause autism’ is not an evidence-based claim because studies have not ruled out the possibility ...

Federal funding cuts to vaccine research have impacted scientists nationwide — and some of those cuts hit close to home.

Q3 2025 Earnings Call November 13, 2025 4:30 PM ESTCompany ParticipantsDavid Dodd - Chairman, President & CEOMark Reynolds ...

Following publication of KEYNOTE-689 Phase 3 results confirming the role of perioperative checkpoint inhibition in head and neck cancer, GeoVax announced plans for a Phase 2 trial (AdPNP-203) ...

Starting in 2025, this year’s flu season is spreading early, and with vaccination rates low and a novel virus strain, health ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...